Business / Finance

RSS

Easton-Bell Sports announces financial results for second quarter 2013

Easton-Bell Sports, Inc. (the "Company"), a leading designer, developer and marketer of branded sports equipment, protective products and related accessories, today announced financial results for the second quarter ended June 29, 2013.

13 Aug 2013

Intercept Pharmaceuticals reports financial results for Second quarter 2013

Intercept Pharmaceuticals, Inc. (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, such as primary biliary cirrhosis, today reported financial results for the quarter and six months ended June 30, 2013 and announced presentations at an upcoming medical conference and upcoming investor conferences.

13 Aug 2013

Cyanotech announces first quarter financial results of fiscal year 2014

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the first quarter of fiscal year 2014, ended June 30, 2013.

12 Aug 2013

Saint-Gobain introduces next-generation Tygon S3 tubing for use in laboratory applications

Saint-Gobain Performance Plastics, the maker of Tygon® high-performance flexible tubing, has become the first manufacturer to introduce a bio-based, phthalate-free product for use in laboratory applications. DEHP Di(2-ethylhexyl phthalate), a common plasticizer, has been removed from existing Tygon® formulations.

12 Aug 2013

Derma Sciences reports financial and operating results for 2013

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and six months ended June 30, 2013.

12 Aug 2013

MyFitnessPal closes $18 million Series to improve health and wellness of millions of users

MyFitnessPal, the leading free personal health and fitness system, today announced it has closed an $18 million Series A round of funding led by Kleiner Perkins Caufield & Byers with participation by Accel Partners. Both John Doerr and Andrew Braccia have also joined the company's board.

12 Aug 2013

Omeros announces financial results for second quarter of 2013

Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.

12 Aug 2013

New reagent kits for intracellular staining from Beckman Coulter Life Sciences

PerFix-Expose1 and PerFix-nc1, innovative new reagent kits for intracellular staining from Beckman Coulter Life Sciences, minimize sample manipulation for a streamlined workflow that delivers high quality results. Developed for use on Beckman Coulter’s Gallios1 and Navios2 series flow cytometers and compatible with all Beckman Coulter Life Sciences’ fluorochromes, the kits enable a clear focus on the cytoplasmic and nuclear compartments of the cell.

8 Aug 2013

TruClinic signs new partnership with University of Utah Hospital's Department of Telemedicine

Today TruClinic announced a new partnership with University of Utah Hospital's Department of Telemedicine, which will enable patients and practitioners to have video-based online visits and consultations with simply a computing device, Internet connection and a webcam.

8 Aug 2013

FitBionic completes $2.2M funding round with KMG Capital Partners, CID4 and High Country Venture

FitBionic has completed a $2.2 million funding round with a team led by KMG Capital Partners, with High Country Venture and the Colorado Institute for Drug, Device and Diagnostic Development. The investment was developed in support of the global launch of FitBionic's currently available first product, the FitBionic Foot, and as a bridge to the company's Series A financing, which is expected in 2014.

8 Aug 2013

MAXIMUS revenue grows 26% to $334.3 million in Q3 2013

MAXIMUS, a leading provider of government services worldwide, today reported financial results for its third quarter ended June 30, 2013.

8 Aug 2013

Lupin acquires exclusive license to promote, distribute Romark's Alinia for Oral Suspension in US

Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.

7 Aug 2013

Molex signs definitive agreements to acquire FCT Electronics Group

Molex Incorporated, a global electronics components company, announced today it has signed definitive agreements to acquire FCT Electronics Group, based in Munich, Germany. FCT Electronics Group specializes in designing and manufacturing custom mixed-layout connectors and cable assemblies.

7 Aug 2013

CVS Caremark net revenues increase 1.7% in Q2 2013

CVS Caremark Corporation today announced operating results for the three months ended June 30, 2013.

6 Aug 2013

Targacept reports net loss of $12.4 million for Q2 2013

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today reported its financial results for the second quarter and six months ended June 30, 2013.

6 Aug 2013

Portage Health inks definitive agreement to form joint venture with LifePoint Hospitals

The Portage Health Board of Directors has signed a definitive agreement to form a joint venture with LifePoint Hospitals. The agreement, which includes $60 million in capital investments over the next 10 years by the new joint venture, would allow Portage Health to expand and enhance its services to better meet the healthcare needs of its communities.

6 Aug 2013

TTY BIOPHARM receives Outstanding Company of the Year award

TTY BIOPHARM was awarded "Outstanding Company of the Year", the highest award given at the Bio Taiwan 2013 Exhibition. At the opening ceremony on July 18, Rong-Jing Lin, Chairman and General Manager of TTY BIOPHARM, received the prize from Ma Ying-jeou, President of Taiwan.

6 Aug 2013

Business / Finance

Easton-Bell Sports announces financial results for second quarter 2013

Intercept Pharmaceuticals reports financial results for Second quarter 2013

Cyanotech announces first quarter financial results of fiscal year 2014

Saint-Gobain introduces next-generation Tygon S3 tubing for use in laboratory applications

Derma Sciences reports financial and operating results for 2013

MyFitnessPal closes $18 million Series to improve health and wellness of millions of users

Omeros announces financial results for second quarter of 2013

New reagent kits for intracellular staining from Beckman Coulter Life Sciences

TruClinic signs new partnership with University of Utah Hospital's Department of Telemedicine

FitBionic completes $2.2M funding round with KMG Capital Partners, CID4 and High Country Venture

MAXIMUS revenue grows 26% to $334.3 million in Q3 2013

Lupin acquires exclusive license to promote, distribute Romark's Alinia for Oral Suspension in US

Molex signs definitive agreements to acquire FCT Electronics Group

CVS Caremark net revenues increase 1.7% in Q2 2013

Targacept reports net loss of $12.4 million for Q2 2013

Portage Health inks definitive agreement to form joint venture with LifePoint Hospitals

TTY BIOPHARM receives Outstanding Company of the Year award

Ensemble Therapeutics initiates research and development collaboration with Novartis

Life Tech, Raintree Launch Oncology Testing, Patient Data Initiatives

Bayer Collaboration Could Net $540M+ For Compugen

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News